생체재료 시장 분석 및 예측(-2035년) : 유형, 제품, 기술, 용도, 재료 유형, 프로세스, 최종 사용자, 기능

The global Biomaterials Market is projected to grow from $168.4 billion in 2025 to $610.9 billion by 2035, at a compound annual growth rate (CAGR) of 13.8%. The biomaterials market is driven by the increasing adoption of implantable medical devices, regenerative medicine, and tissue engineering technologies. According to the U.S. FDA, biomaterials such as titanium, cobalt-chromium, polymers, ceramics, and bioresorbable materials are widely used in implantable devices, including orthopedic implants, dental devices, and cardiovascular applications. The FDA continues to expand safety evaluations for commonly used medical device materials, supporting innovation in biocompatible and advanced biomaterials.

The Type segment of the Biomaterials Market includes natural biomaterials, synthetic biomaterials, metallic biomaterials, ceramic biomaterials, polymeric biomaterials, composite biomaterials, and others. Among these, polymeric biomaterials and metallic biomaterials hold significant market shares due to their wide use in medical implants, tissue engineering, drug delivery systems, and orthopedic applications. Polymeric biomaterials are increasingly adopted owing to their flexibility, biodegradability, and compatibility with various biomedical applications, while metallic biomaterials such as titanium and stainless steel are preferred for their high strength, durability, and load-bearing capabilities in implants. Natural biomaterials are gaining traction due to their excellent biocompatibility and ability to support tissue regeneration, whereas composite biomaterials are expanding due to their enhanced mechanical properties and multifunctional performance in advanced healthcare applications.

The End User segment of the Biomaterials Market includes hospitals, research laboratories, ambulatory surgical centers, biotechnology companies, pharmaceutical companies, and others. Hospitals represent a major end-user segment due to the increasing adoption of biomaterial-based implants, prosthetics, wound care products, and regenerative medicine solutions in clinical procedures. Research laboratories are witnessing strong growth as advancements in tissue engineering, nanotechnology, and regenerative medicine drive biomaterials research and development activities. Biotechnology and pharmaceutical companies are increasingly utilizing biomaterials for drug delivery systems, biologics development, and novel therapeutic solutions, while ambulatory surgical centers are contributing to market growth through the rising number of minimally invasive procedures and outpatient surgeries requiring advanced biomaterial-based products.

Geographical Overview

North America accounted for the largest share of the global biomaterials market in 2025, driven by its advanced healthcare infrastructure, high healthcare expenditure, and strong presence of leading medical device and biotechnology companies. The region has witnessed increasing adoption of biomaterials in orthopedic implants, cardiovascular devices, dental applications, wound healing products, and tissue engineering. Continuous investments in regenerative medicine, growing demand for minimally invasive procedures, and favorable reimbursement policies have further accelerated market growth. In addition, extensive research collaborations between universities, research institutes, and medical device manufacturers, coupled with stringent quality standards and rapid commercialization of innovative biomaterial technologies, continue to strengthen North America's leadership in the global biomaterials market.

Asia Pacific is projected to witness the highest growth in the biomaterials market owing to rapid expansion of healthcare infrastructure, rising medical tourism, and increasing investments in advanced medical technologies. Countries such as China, India, Japan, and South Korea are experiencing growing demand for orthopedic, dental, cardiovascular, and cosmetic procedures due to aging populations and rising chronic disease prevalence. Government initiatives supporting domestic medical device manufacturing, expanding biotechnology research, and improving access to advanced healthcare services are further fueling market growth. Moreover, lower manufacturing costs, increasing clinical research activities, and the growing presence of international biomaterial manufacturers are expected to position Asia Pacific as the fastest-growing regional market throughout the forecast period.

Key Trends and Drivers

Increasing Adoption of Bio-based and Sustainable Biomaterials:

The Biomaterials Market is witnessing a growing trend toward the development and adoption of bio-based, biodegradable, and sustainable biomaterials. Manufacturers are investing in naturally derived polymers, bioresorbable implants, and eco-friendly materials that minimize long-term environmental impact while improving patient safety. Advances in material science and tissue engineering have enabled the production of biomaterials with enhanced biocompatibility, mechanical strength, and regenerative capabilities. These innovations are expanding applications in orthopedic implants, cardiovascular devices, wound care, and dental products. As healthcare systems increasingly prioritize sustainable and patient-centric solutions, demand for advanced biomaterials is expected to accelerate globally.

Rising Demand for Advanced Medical Implants and Tissue Engineering:

The increasing prevalence of chronic diseases, musculoskeletal disorders, cardiovascular conditions, and age-related health issues is driving demand for advanced medical implants and regenerative therapies, fueling the Biomaterials Market. A growing aging population and rising number of surgical procedures worldwide have increased the need for high-performance biomaterials used in orthopedic, dental, cardiovascular, and ophthalmic applications. Furthermore, rapid advancements in tissue engineering, 3D bioprinting, and regenerative medicine have expanded the use of biomaterials in developing next-generation medical devices and artificial tissues. Continuous investments in biomedical research and healthcare infrastructure are further supporting market growth.

Research Scope

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Application
• 2.4 Key Market Highlights by Material Type
• 2.5 Key Market Highlights by Technology
• 2.6 Key Market Highlights by End User
• 2.7 Key Market Highlights by Functionality
• 2.8 Key Market Highlights by Process

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Natural Biomaterials
  • 4.1.2 Synthetic Biomaterials
  • 4.1.3 Metallic Biomaterials
  • 4.1.4 Ceramic Biomaterials
  • 4.1.5 Polymeric Biomaterials
  • 4.1.6 Composite Biomaterials
  • 4.1.7 Others
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Scaffolds
  • 4.2.2 Hydrogels
  • 4.2.3 Nanomaterials
  • 4.2.4 Biocompatible Coatings
  • 4.2.5 Bioactive Glasses
  • 4.2.6 Others
• 4.3 Market Size & Forecast by Application (2020-2035)
  • 4.3.1 Orthopedic
  • 4.3.2 Cardiovascular
  • 4.3.3 Dental
  • 4.3.4 Ophthalmology
  • 4.3.5 Wound Healing
  • 4.3.6 Tissue Engineering
  • 4.3.7 Drug Delivery
  • 4.3.8 Plastic Surgery
  • 4.3.9 Neurology
  • 4.3.10 Others
• 4.4 Market Size & Forecast by Material Type (2020-2035)
  • 4.4.1 Biodegradable
  • 4.4.2 Non-biodegradable
  • 4.4.3 Bioinert
  • 4.4.4 Bioactive
  • 4.4.5 Others
• 4.5 Market Size & Forecast by Technology (2020-2035)
  • 4.5.1 3D Printing
  • 4.5.2 Electrospinning
  • 4.5.3 Nanotechnology
  • 4.5.4 Surface Modification
  • 4.5.5 Others
• 4.6 Market Size & Forecast by End User (2020-2035)
  • 4.6.1 Hospitals
  • 4.6.2 Research Laboratories
  • 4.6.3 Ambulatory Surgical Centers
  • 4.6.4 Biotechnology Companies
  • 4.6.5 Pharmaceutical Companies
  • 4.6.6 Others
• 4.7 Market Size & Forecast by Functionality (2020-2035)
  • 4.7.1 Biocompatibility
  • 4.7.2 Bioactivity
  • 4.7.3 Biofunctionality
  • 4.7.4 Biodegradability
  • 4.7.5 Others
• 4.8 Market Size & Forecast by Process (2020-2035)
  • 4.8.1 Extrusion
  • 4.8.2 Injection Molding
  • 4.8.3 Solvent Casting
  • 4.8.4 Freeze Drying
  • 4.8.5 Others

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Application
    • 5.2.1.4 Material Type
    • 5.2.1.5 Technology
    • 5.2.1.6 End User
    • 5.2.1.7 Functionality
    • 5.2.1.8 Process
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Application
    • 5.2.2.4 Material Type
    • 5.2.2.5 Technology
    • 5.2.2.6 End User
    • 5.2.2.7 Functionality
    • 5.2.2.8 Process
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Application
    • 5.2.3.4 Material Type
    • 5.2.3.5 Technology
    • 5.2.3.6 End User
    • 5.2.3.7 Functionality
    • 5.2.3.8 Process
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Application
    • 5.3.1.4 Material Type
    • 5.3.1.5 Technology
    • 5.3.1.6 End User
    • 5.3.1.7 Functionality
    • 5.3.1.8 Process
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Application
    • 5.3.2.4 Material Type
    • 5.3.2.5 Technology
    • 5.3.2.6 End User
    • 5.3.2.7 Functionality
    • 5.3.2.8 Process
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Application
    • 5.3.3.4 Material Type
    • 5.3.3.5 Technology
    • 5.3.3.6 End User
    • 5.3.3.7 Functionality
    • 5.3.3.8 Process
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Application
    • 5.4.1.4 Material Type
    • 5.4.1.5 Technology
    • 5.4.1.6 End User
    • 5.4.1.7 Functionality
    • 5.4.1.8 Process
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Application
    • 5.4.2.4 Material Type
    • 5.4.2.5 Technology
    • 5.4.2.6 End User
    • 5.4.2.7 Functionality
    • 5.4.2.8 Process
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Application
    • 5.4.3.4 Material Type
    • 5.4.3.5 Technology
    • 5.4.3.6 End User
    • 5.4.3.7 Functionality
    • 5.4.3.8 Process
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Application
    • 5.4.4.4 Material Type
    • 5.4.4.5 Technology
    • 5.4.4.6 End User
    • 5.4.4.7 Functionality
    • 5.4.4.8 Process
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Application
    • 5.4.5.4 Material Type
    • 5.4.5.5 Technology
    • 5.4.5.6 End User
    • 5.4.5.7 Functionality
    • 5.4.5.8 Process
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Application
    • 5.4.6.4 Material Type
    • 5.4.6.5 Technology
    • 5.4.6.6 End User
    • 5.4.6.7 Functionality
    • 5.4.6.8 Process
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Application
    • 5.4.7.4 Material Type
    • 5.4.7.5 Technology
    • 5.4.7.6 End User
    • 5.4.7.7 Functionality
    • 5.4.7.8 Process
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Application
    • 5.5.1.4 Material Type
    • 5.5.1.5 Technology
    • 5.5.1.6 End User
    • 5.5.1.7 Functionality
    • 5.5.1.8 Process
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Application
    • 5.5.2.4 Material Type
    • 5.5.2.5 Technology
    • 5.5.2.6 End User
    • 5.5.2.7 Functionality
    • 5.5.2.8 Process
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Application
    • 5.5.3.4 Material Type
    • 5.5.3.5 Technology
    • 5.5.3.6 End User
    • 5.5.3.7 Functionality
    • 5.5.3.8 Process
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Application
    • 5.5.4.4 Material Type
    • 5.5.4.5 Technology
    • 5.5.4.6 End User
    • 5.5.4.7 Functionality
    • 5.5.4.8 Process
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Application
    • 5.5.5.4 Material Type
    • 5.5.5.5 Technology
    • 5.5.5.6 End User
    • 5.5.5.7 Functionality
    • 5.5.5.8 Process
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Application
    • 5.5.6.4 Material Type
    • 5.5.6.5 Technology
    • 5.5.6.6 End User
    • 5.5.6.7 Functionality
    • 5.5.6.8 Process
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Application
    • 5.6.1.4 Material Type
    • 5.6.1.5 Technology
    • 5.6.1.6 End User
    • 5.6.1.7 Functionality
    • 5.6.1.8 Process
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Application
    • 5.6.2.4 Material Type
    • 5.6.2.5 Technology
    • 5.6.2.6 End User
    • 5.6.2.7 Functionality
    • 5.6.2.8 Process
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Application
    • 5.6.3.4 Material Type
    • 5.6.3.5 Technology
    • 5.6.3.6 End User
    • 5.6.3.7 Functionality
    • 5.6.3.8 Process
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Application
    • 5.6.4.4 Material Type
    • 5.6.4.5 Technology
    • 5.6.4.6 End User
    • 5.6.4.7 Functionality
    • 5.6.4.8 Process
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Application
    • 5.6.5.4 Material Type
    • 5.6.5.5 Technology
    • 5.6.5.6 End User
    • 5.6.5.7 Functionality
    • 5.6.5.8 Process

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 BASF
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 DSM
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Corbion
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Evonik Industries
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 Zimmer Biomet
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Medtronic
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Johnson and Johnson
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Stryker Corporation
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Royal DSM
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Invibio
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Victrex
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Collagen Solutions
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Straumann
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Berkeley Advanced Biomaterials
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Covestro
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Toray Industries
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 Kuraray
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Solvay
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 Biomet 3i
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Wright Medical Group
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us